The Effect of CYP3A5 and MDR1 Polymorphic Expression on Cyclosporine Oral Disposition in Renal Transplant Patients (Q58869670)

From Wikidata

Jump to navigation Jump to search

scholarly article by Charles R. Yates et al published June 2003 in The Journal of Clinical Pharmacology

Language	Label	Description	Also known as
English	The Effect of CYP3A5 and MDR1 Polymorphic Expression on Cyclosporine Oral Disposition in Renal Transplant Patients	scholarly article by Charles R. Yates et al published June 2003 in The Journal of Clinical Pharmacology

Statements

scholarly article

0 references

The Effect of CYP3A5 and MDR1 Polymorphic Expression on Cyclosporine Oral Disposition in Renal Transplant Patients (English)

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

8

object named as

Rita R. Alloway

0 references

author name string

Charles R. Yates

1

0 references

Wenhui Zhang

2

0 references

Pengfei Song

3

0 references

Shen Li

4

0 references

A. Osama Gaber

5

0 references

Malak Kotb

6

0 references

Marsha R. Honaker

7

0 references

Bernd Meibohm

9

0 references

publication date

June 2003

0 references

The Journal of Clinical Pharmacology

0 references

43

0 references

6

0 references

555-564

0 references

Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Identification of functionally variant MDR1 alleles among European Americans and African Americans

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Gender-dependent racial difference in disposition of cyclosporine among healthy African American and white volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Detection of MDR1 single nucleotide polymorphisms C3435T and G2677T using real-time polymerase chain reaction: MDR1 single nucleotide polymorphism genotyping assay

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

The importance of modeling interoccasion variability in population pharmacokinetic analyses

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Patient management by Neoral C(2) monitoring: an international consensus statement

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Frequency of C3435T polymorphism of MDR1 gene in African people

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Therapeutic concentrations of cyclosporine A, but not FK506, increase P-glycoprotein expression in endothelial and renal tubule cells

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

[29] Polymerase chain reaction amplification of specific alleles: A general method of detection of mutations, polymorphisms, and haplotypes

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study Group

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Low bioavailability of cyclosporine microemulsion and tacrolimus in a small bowel transplant recipient: possible relationship to intestinal P-glycoprotein activity

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Cyclosporine nephrotoxicity is minimized by adjusting dosage on the basis of drug concentration in blood

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253617

21 January 2018

Identifiers

10.1177/0091270003253617

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58869670&oldid=2069677419"